Salesforce (CRM) — The Transparent Read
28/100Bearish$157.93 · downtrend
This is a bearish chart with a faint macro tailwind, and the technicals win the argument for now. CRM is in a confirmed downtrend — below both moving averages, post-death-cross, with fading momentum and a 28.2 composite score. The 55% macro base rate and median +1.7% are real but mild, the kind of edge that gets overwhelmed by a trend this heavy. My lean is cautious-to-bearish near term: respect the $146.32 support, and don't mistake a neutral RSI for a bottom. The burden of proof is on the bulls, and the chart hasn't given them anything yet.
CRM key levels
Show Your Work — every point in CRM's score
The score starts at 50, then each signal below adds or subtracts points. No black box.
| Signal | Type | Points |
|---|---|---|
| Below 200-day MA Price is below its 200-day average — long-term trend is down. | technical | -8 |
| Below 50-day MA Trading below the 50-day average — medium-term momentum is weak. | technical | -5 |
| Death cross 50-day average is below the 200-day (death cross). | technical | -4 |
| RSI neutral RSI is 41 — neither overbought nor oversold. | technical | -0.89 |
| MACD negative MACD is below its signal line — momentum is fading. | technical | -5 |
| Macro regime base rate In 38 past periods like today (Rising inflation + Steady Fed), this stock was higher 90d later 55% of the time (median +1.7%). Historically favorable. | macro | +1.05 |
Macro regime base rate
Today's regime: Rising inflation + Steady Fed
In 38 past periods that looked like today, CRM was higher 90 days later 55% of the time (median move 1.7%). Confidence: high.
The read
CRM Stuck in a Downtrend — Bears Hold the Wheel Until $175 Says Otherwise
Bull case. There are a few threads for the optimists to pull. RSI at 41 is neutral, not stretched — meaning the stock isn't oversold and washed out, leaving room for a bounce without forcing distressed selling. Price sits at $157.93, comfortably above the $146.32 support floor, so the structure hasn't broken down completely. And the macro backdrop is quietly constructive: in 38 analogous periods of rising inflation with a steady Fed, CRM was higher 90 days later 55% of the time with a median gain of +1.7% (high confidence). That's a modest but real edge for patient buyers.
Bear case. The technical damage is hard to ignore. Price is below both the 50-day MA ($175.42) and the 200-day MA ($212.40) — and the 50-day is below the 200-day, confirming a death cross and a firmly entrenched downtrend. The MACD histogram at -0.91 shows momentum below its signal line and fading, not turning. The composite score of 28.2/100 is decisively bearish. Every major trend signal points the same direction: down. The path of least resistance remains lower until proven otherwise.
What would change my mind. A decisive reclaim of the 50-day MA at $175.42 — ideally with the MACD histogram flipping positive — would tell me momentum is genuinely turning and the downtrend is losing its grip. Conversely, a close below $146.32 support confirms the bear case and opens the door to further downside.
CRM — frequently asked
Is CRM a buy according to Tallyread?
Tallyread does not give buy or sell recommendations. It shows a transparent 28/100 read for Salesforce (CRM), conditioned on today's macro regime, with every scoring input itemized so you can judge for yourself. This is not financial advice.
How is CRM's Tallyread score calculated?
The 28/100 score starts at 50, then adds and subtracts named technical and macro signals — each shown with its point value and a one-line reason in the "Show Your Work" table on this page. Nothing is hidden in a black box.
How does today's Fed-and-inflation regime affect CRM?
In 38 past periods whose macro regime matched today's (Rising inflation + Steady Fed), CRM was higher 90 days later 55% of the time, with a median move of 1.7%. Confidence: high.
Want a fresh read on CRM with the live chart and macro tape?
Run a live CRM read →Last analyzed 2026-06-30 · Data source: tiingo. See the public scorecard and methodology.
This is a historical and technical read for informational and educational purposes only — not financial advice, and not a recommendation to buy or sell CRM. Markets are uncertain; do your own research.